Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:19 PM ET 8-K
Loan & Debt Cleanspark, Inc. CLSK

Cleanspark $2.28B Debt Financing

CleanSpark's subsidiary, CSDC Finance I, LLC, priced a $2.276 billion offering of 7.875% senior secured notes due 2031. The proceeds will be used to finance the remaining build-out of the Sandersville Facility data center, reimburse prior equity contributions, and fund debt service reserves.

Value
$2.28B
Term
5 years
5:18 PM ET Form 4
Insider Selling Pagaya Technologies Ltd. PGY

Pagaya Technologies Insider Tami Rosen Sells $173K of Stock

Tami Rosen sold 8,504 shares of Pagaya Technologies Ltd. at $20.38 a share, worth $173K in total on Sep 18, 2026. Shares held after the trade: 15,400 (-35.6%).

Value
$173K
Shares
8,504
Price
$20.38
Holding change
-35.6%
Trade date
Sep 18, 2026
5:17 PM ET 8-K
M&A Deal Theravance Biopharma, Inc. TBPH

Theravance Biopharma M&A Deal with Zymeworks Inc.

Theravance Biopharma shareholders approved the company's acquisition by Zymeworks Inc. at an extraordinary general meeting. Under the terms of the merger agreement, Theravance will become a wholly owned subsidiary of Zymeworks. The approval included the merger plan, the contingent value rights agreement, and related corporate restructuring.

Counterparty
Zymeworks Inc.
5:17 PM ET 8-K
Executive Compensation Q/C Technologies, Inc. QCLS

Q/C Technologies Executive Compensation

Q/C Technologies appointed Dr. Yossef Ehrlichman as Chief Technology Officer and entered into an amended employment agreement. The agreement includes an annual base salary of $275,000 and a restricted stock award with a grant date fair market value of $250,000, subject to stockholder approval of a share reserve increase. Dr. Ehrlichman previously served as the company's Founding Manager of Photonic Integrated Circuit Development.

Counterparty
Yossef Ehrlichman
Term
at-will
5:16 PM ET Form 4
Insider Buying 5C Lending Partners Corp.

5C Lending Partners 10% Owner LIBERTY MUTUAL HOLDING Co INC. Buys $9.76M of Stock

LIBERTY MUTUAL HOLDING Co INC., 10% Owner, bought 398,774 shares of 5C Lending Partners Corp. at $24.48 a share, worth $9.76M in total on Sep 17, 2026. Shares held after the trade: 4,182,050 (+10.5%).

Value
$9.76M
Shares
398,774
Price
$24.48
Role
10% Owner
Holding change
+10.5%
Trade date
Sep 17, 2026
5:16 PM ET 8-K
Loan & Debt CDT Equity Inc. CDT

CDT Equity $2.13M Debt Financing with J.J. Astor & Co.

CDT Equity Inc. issued a $2.13 million senior secured convertible promissory note to J.J. Astor & Co., receiving net proceeds of approximately $1.5 million. The note matures in March 2027 and is secured by a first priority lien on company assets, with repayment supported by proceeds from the company's existing at-the-market offering program. In connection with the debt, the company also issued warrants to purchase approximately 3.47 million shares of common stock at $0.25 per share.

Value
$2.13M
Counterparty
J.J. Astor & Co.
Term
through March 1, 2027
5:13 PM ET Form 4
Insider Selling Nvidia Corp NVDA

Nvidia EVP & CFO Colette Kress Sells $7.65M of Stock

Colette Kress, EVP & CFO, sold 34,918 shares of Nvidia Corp at $218.01 to $219.59 a share (average $219.05) in 3 transactions, worth $7.65M in total on Sep 17, 2026. Shares held after the trade: 765,103 (-1.3%).

Value
$7.65M
Shares
34,918
Average price
$219.05
Role
EVP & CFO
Holding change
-1.3%
Trade date
Sep 17, 2026
5:12 PM ET 8-K
Nasdaq/NYSE Compliance Notice InMed Pharmaceuticals Inc. MTRI

InMed Pharmaceuticals Nasdaq/NYSE Compliance Notice

InMed Pharmaceuticals received a deficiency notice from Nasdaq for failing to maintain the minimum $2.5 million shareholders' equity requirement for continued listing. The company reported shareholders' equity of $1,075,007, largely due to expenses related to its pending merger with Mentari Therapeutics. InMed expects to regain compliance upon the closing of the merger, which is anticipated to bring approximately $490 million in gross proceeds to the combined company.

Counterparty
The Nasdaq Stock Market LLC
Term
45 days to submit plan
5:11 PM ET 8-K
Leadership Change Glucotrack, Inc. GCTK

Glucotrack Leadership Change

Paul V. Goode resigned from the Board of Directors of Glucotrack, Inc. effective September 14, 2026. Mr. Goode cited a potential conflict of interest between the company and its subsidiary regarding the implementation of duties and rights under a prior merger agreement with Lokahi Therapeutics, Inc.

Counterparty
Paul V. Goode
5:05 PM ET Form 4
Insider Selling Metropolitan Bank Holding Corp. MCB

Metropolitan Bank Holding Director Dale C. Fredston Sells $178K of Stock

Dale C. Fredston, Director, sold 2,000 shares of Metropolitan Bank Holding Corp. at $89.09 a share, worth $178K in total on Sep 17, 2026. Shares held after the trade: 14,668 (-12.0%).

Value
$178K
Shares
2,000
Price
$89.09
Role
Director
Holding change
-12.0%
Trade date
Sep 17, 2026
5:01 PM ET 8-K
Investor Presentation Atossa Therapeutics, Inc. ATOS

Atossa Therapeutics Investor Presentation

Atossa Therapeutics made available an updated corporate and investor presentation on September 18, 2026, highlighting its clinical development strategy for (Z)-Endoxifen. The presentation covers the company's oncology core and rare disease expansion, including Phase 2 progress in breast cancer and regulatory designations for McCune-Albright Syndrome and Duchenne Muscular Dystrophy.

5:01 PM ET 8-K
Investor Presentation Civista Bancshares, Inc. CIVB

Civista Bancshares Investor Presentation

Civista Bancshares announced its participation in the Stephens 16th Annual Bank Forum on September 23-24, 2026, in Little Rock, Arkansas. The company furnished its Q2 2026 Investor Presentation, highlighting its $4.3 billion asset base, 1.34% ROAA, and strategic leadership transition under new CEO Chuck Parcher.

Counterparty
Stephens 16th Annual Bank Forum
5:01 PM ET 8-K
Other 8-K Filing IT Tech Packaging, Inc. ITP

IT Tech Packaging Other 8-K Filing

IT Tech Packaging, Inc. reported that its independent registered public accounting firm, HCL, PLLC, resigned effective September 16, 2026, only two weeks after being engaged. No audit reports had been issued and no disagreements on accounting principles or practices were reported during the brief engagement period. The company is currently seeking a successor auditor to complete its fiscal year 2025 financial statement audit.

Counterparty
HCL, PLLC
5:01 PM ET 8-K/A
Loan & Debt Change Agents Corporation. CHGA

Change Agents Debt Financing Update with certain accredited investors

Change Agents Corporation issued $280,000 in aggregate principal amount of original issue discount (OID) promissory notes maturing in April 2027. The notes carry a 7% annual interest rate and were issued for gross proceeds of $250,000, which will be used to repay existing debt and for working capital. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock.

Counterparty
certain accredited investors
Term
7 months
5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Moleculin Biotech, Inc. MBRX

Moleculin Biotech Nasdaq/NYSE Compliance Notice

Moleculin Biotech received a Staff Determination Letter from Nasdaq notifying the company that its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Because the company already performed a reverse stock split within the last year, it is ineligible for the standard 180-day grace period and faces immediate delisting unless it successfully appeals to the Nasdaq Hearings Panel.

Counterparty
The Nasdaq Stock Market LLC
5:01 PM ET 8-K
Other 8-K Filing Bpgc Acquisition Corp. ROSS

Bpgc Acquisition Other 8-K Filing

BPGC Acquisition Corp. shareholders approved an amendment to extend the deadline for completing a business combination from September 16, 2026, to March 16, 2028. In connection with the vote, holders of 22,566 Class A ordinary shares exercised their redemption rights at a price of approximately $12.22 per share, totaling roughly $0.28 million.

Term
through March 16, 2028
5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Fusemachines Inc. FUSE

Fusemachines Nasdaq/NYSE Compliance Notice

Fusemachines Inc. received a deficiency notice from Nasdaq on September 18, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive business days. The company has 180 calendar days, or until March 17, 2027, to regain compliance by maintaining a bid price of at least $1.00 for 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
5:00 PM ET Form 4
Insider Buying Eastern International Ltd. ELOG

Eastern International CEO Albert Wong Buys $200K of Stock

Albert Wong, CEO, bought 200,000 shares of Eastern International Ltd. at $1.00 a share, worth $200K in total on Aug 27, 2026. Shares held after the trade: 200,000.

Value
$200K
Shares
200,000
Price
$1.00
Role
CEO
Trade date
Aug 27, 2026
4:56 PM ET 8-K
Partnership RTB Digital, Inc. RTB

RTB Digital Partnership with Paradium.AI, Inc. Worth $1B

RTB Digital signed a ten-year Strategic Platform Agreement with Paradium.AI to migrate Paradium's premium media brands and associated revenue to RTB's AI-powered digital media and business operations platform. The partnership is expected to generate approximately $100 million in annual gross revenue and $1 billion over the ten-year term through a revenue-sharing model. RTB will provide full-stack services including publishing, advertising, and DeFi-driven payments while Paradium grants RTB certain technology licenses and operational resources.

Value
$1B
Counterparty
Paradium.AI, Inc.
Term
10 years
4:55 PM ET 8-K
Stock Plan Amendment Lennox International Inc LII

Lennox International Stock Plan Amendment

Lennox International approved a new form of Long-Term Incentive Award Agreement for U.S. employees at the Vice President level and above under its 2019 Equity and Incentive Compensation Plan. The updated agreement, which covers restricted stock units, performance share units, and stock appreciation rights, includes revised vesting and exercise schedules and retirement eligibility terms.

4:55 PM ET Form 4
Insider Selling Barfresh Food Group Inc. BRFH

Barfresh Food Group Insider Lisa Roger Sells $27.9K of Stock

Lisa Roger sold 25,329 shares of Barfresh Food Group Inc. at $1.10 a share, worth $27.9K in total on Sep 17, 2026. Shares held after the trade: 46,414 (-35.3%).

Value
$27.9K
Shares
25,329
Price
$1.10
Holding change
-35.3%
Trade date
Sep 17, 2026
4:53 PM ET Form 4
Insider Selling Lumentum Holdings Inc. LITE

Lumentum Holdings President, Global Bus. Units Yuen Wupen Sells $1.36M of Stock

Yuen Wupen, President, Global Bus. Units, sold 1,500 shares of Lumentum Holdings Inc. at $856.83 to $933.45 a share (average $903.43) in 3 transactions, worth $1.36M in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 111,627 (-0.4%).

Value
$1.36M
Shares
1,500
Average price
$903.43
Role
President, Global Bus. Units
Holding change
-0.4%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:52 PM ET Form 4
Insider Selling Ambarella Inc AMBA

Ambarella CEO Feng-Ming Wang Sells $395K of Stock

Feng-Ming Wang, CEO, sold 6,086 shares of Ambarella Inc at $64.83 a share, worth $395K in total on Sep 17, 2026. Shares held after the trade: 767,759 (-0.8%).

Value
$395K
Shares
6,086
Price
$64.83
Role
CEO
Holding change
-0.8%
Trade date
Sep 17, 2026
4:52 PM ET 8-K
Leadership Change Concentrix Corp CNXC

Concentrix Leadership Change

Cormac Twomey, Executive Vice President of Customer Success, will step down from his role at Concentrix Corporation effective December 31, 2026. Following his departure, Mr. Twomey will provide transition support services as a consultant for a 60-day period and receive severance benefits in accordance with the company's executive severance plan.

Counterparty
Cormac Twomey
4:52 PM ET 8-K
M&A Deal Medalist Diversified, Inc. MDRR

Medalist Diversified Signs $5.4M M&A Deal with NPH Ventures, LLC

Medalist Diversified, Inc. completed the acquisition of a Caliber Collision Center property in Aubrey, Texas, for a total purchase price of approximately $5.4 million. The acquisition was funded with cash on hand and executed through a Delaware statutory trust (DST). The company intends to offer beneficial interests in the DST to accredited investors via a private placement to redeem its own interests for cash.

Value
$5.4M
Counterparty
NPH Ventures, LLC
4:51 PM ET Form 4
Insider Selling Ambarella Inc AMBA

Ambarella Senior VP, Systems & GM Chi-Hong Ju Sells $130K of Stock

Chi-Hong Ju, Senior VP, Systems & GM, sold 2,009 shares of Ambarella Inc at $64.83 a share, worth $130K in total on Sep 17, 2026. Shares held after the trade: 154,153 (-1.3%).

Value
$130K
Shares
2,009
Price
$64.83
Role
Senior VP, Systems & GM
Holding change
-1.3%
Trade date
Sep 17, 2026
4:51 PM ET Form 4
Insider Selling Ambarella Inc AMBA

Ambarella Chief Operations Officer Chan W. Lee Sells $188K of Stock

Chan W. Lee, Chief Operations Officer, sold 2,893 shares of Ambarella Inc at $64.83 a share, worth $188K in total on Sep 17, 2026. Shares held after the trade: 154,443 (-1.8%).

Value
$188K
Shares
2,893
Price
$64.83
Role
Chief Operations Officer
Holding change
-1.8%
Trade date
Sep 17, 2026
4:50 PM ET Form 4
Insider Selling Ambarella Inc AMBA

Ambarella CFO John Alexander Young Sells $203K of Stock

John Alexander Young, CFO, sold 3,126 shares of Ambarella Inc at $64.83 a share, worth $203K in total on Sep 17, 2026. Shares held after the trade: 109,702 (-2.8%).

Value
$203K
Shares
3,126
Price
$64.83
Role
CFO
Holding change
-2.8%
Trade date
Sep 17, 2026
4:49 PM ET Form 4
Insider Selling Xos, Inc. XOS

Xos Director Dietmar Ostermann Sells $12.1K of Stock

Dietmar Ostermann, Director, sold 4,738 shares of Xos, Inc. at $2.55 a share, worth $12.1K in total on Sep 17, 2026. Shares held after the trade: 85,226 (-5.3%).

Value
$12.1K
Shares
4,738
Price
$2.55
Role
Director
Holding change
-5.3%
Trade date
Sep 17, 2026
4:48 PM ET Form 4
Insider Selling Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings CMO Kumar Budur Sells $1.66M of Stock

Kumar Budur, CMO, sold 38,452 shares of Harmony Biosciences Holdings, Inc. at $43.00 to $43.05 a share (average $43.05) in 3 transactions, worth $1.66M in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 13,115 (-73.2%).

Value
$1.66M
Shares
38,452
Average price
$43.05
Role
CMO
Holding change
-73.2%
Trade date
Sep 16, 2026 to Sep 18, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.